Skip to main navigation menu Skip to main content Skip to site footer


Vol. 145 No. 5152 (2015)

Screening for liver cancer in high risk patients in Switzerland: Yes, it works, but No, we do not do it systematically!

  • Andreas Cerny
Cite this as:
Swiss Med Wkly. 2015;145:w14231


  1. Frey RS, Boldanova T, Heim M. Ultrasound surveillance for hepatocellular carcinoma: real-life performance in a hepatology outpatient clinic. Swiss Med Wkly. 2015;145:w14200.
  2. Dufour J-F, Bordoni A, Lorez M and the NICER Working Group. Trends in hepatic cancer survival in Switzerland. Schweizer Krebsbulletin. 2014;1:46–50.
  3. Trinchet J-C, Bourcier V, Chaffaut C, Ahmed MA, Alam S, Marcellin P, et al. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir Prospective Cohort) Hepatology. 2015;62:737–50.
  4. Cebolla B, Björnberg. Health Consumer Powerhouse: Euro Hepatitis Index 2012 Report ISBN 978-91-980687-0-2.
  5. Al Hasani F, Knoepfli M, Gemperli A, Kollar A, Banz V, Kettenbach J, et al. Annals of Hepatol. 2014;12(2):204–10.
  6. Fretz R, Negro F, Bruggmann P, Lavanchy, De Gottardi A, Pache I, et al. Hepatitis B and C in Switzerland – healthcare provider initiated testing for chronic hepatitis B and C infection. Swiss Med Wkly. May 17;143:w13793. doi: 10.4414/smw.2013.13793.

Most read articles by the same author(s)